This is part of a larger recall. The most authoritative record is FDA-Drug / D-0082-2027.
Par Argatroban Injection recalled for particulate matter contamination
What this means
Par Pharmaceutical's Argatroban Injection vials have been found to contain small particles of cellulose, polystyrene, polyethylene terephthalate, stainless steel, or stopper material in the solution. This affects specific lot numbers distributed nationwide. The contamination was identified during quality testing.
- Check if you have Argatroban Injection lot #84193 (expires 10/2026) or lot #92880 (expires 08/2027).
- Do not use affected vials.
- Contact your pharmacy or hospital supplier immediately to report and return contaminated vials.
- Consult your doctor or healthcare provider about alternative anticoagulation therapy if doses were scheduled.
The agency's original wording
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0083-2027More Paragon 28 recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.